Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Acer Therapeutics Inc ACER

Acer Therapeutics Inc ???????,?????????????????????????????,??????????????????????????OLPRUVA(????)?ACER-801(????)?EDSIVO(????)???????OLPRUVA(????)?????????,?????????????,????????(UCDs)??????(MSUD)??ACER-801(????)????????????????(NK3R)???,????????(VMS)????????(PTSD)???????EDSIVO(????)??????????????,???????III?????(COL3A1)????????Ehlers-Danlos???(vEDS)?

OTCPK:ACER - Post Discussion

Acer Therapeutics Inc > Acer Therapeutics - new article on Seeking Alpha
View:
Post by allison5120 on Sep 25, 2018 8:24am

Acer Therapeutics - new article on Seeking Alpha

See new article on Seeking Alpha on $ACER. Potentially very lucrative business model. 2 drugs in pipeline. EDSIVO - could be filing NDA as early as October, 2018 with potential PDUFA date in late Q2 2019.  https://seekingalpha.com/article/4208065-acer-therapeutics-focus-rare-ultra-rare-diseases-potentially-lucrative-business-model  I've been accumulating shares over the past month.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities